Literature DB >> 25049249

Chloroquine remains effective for treating Plasmodium vivax malaria in Pursat province, Western Cambodia.

Chanaki Amaratunga1, Sokunthea Sreng2, Sivanna Mao3, Gregory S Tullo1, Jennifer M Anderson1, Char Meng Chuor2, Seila Suon2, Rick M Fairhurst4.   

Abstract

Chloroquine (CQ) is used to treat Plasmodium vivax malaria in areas where CQ resistance has not been reported. The use of artemisinin (ART)-based combination therapies (ACTs) to treat CQ-sensitive P. vivax infections is effective and convenient but may promote the emergence and worsening of ART resistance in sympatric Plasmodium falciparum populations. Here, we show that CQ effectively treats P. vivax malaria in Pursat Province, western Cambodia, where ART-resistant P. falciparum is highly prevalent and spreading. (This study has been registered at ClinicalTrials.gov under registration no. NCT00663546.).
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25049249      PMCID： PMC4187907          DOI： 10.1128/AAC.03026-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Authors:  Frédéric Ariey; Benoit Witkowski; Chanaki Amaratunga; Johann Beghain; Anne-Claire Langlois; Nimol Khim; Saorin Kim; Valentine Duru; Christiane Bouchier; Laurence Ma; Pharath Lim; Rithea Leang; Socheat Duong; Sokunthea Sreng; Seila Suon; Char Meng Chuor; Denis Mey Bout; Sandie Ménard; William O Rogers; Blaise Genton; Thierry Fandeur; Olivo Miotto; Pascal Ringwald; Jacques Le Bras; Antoine Berry; Jean-Christophe Barale; Rick M Fairhurst; Françoise Benoit-Vical; Odile Mercereau-Puijalon; Didier Ménard
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

Review 2.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

3.  Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Authors:  Rithea Leang; Amy Barrette; Denis Mey Bouth; Didier Menard; Rashid Abdur; Socheat Duong; Pascal Ringwald
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

Review 4.  Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.

Authors:  Nithya Gogtay; Sridharan Kannan; Urmila M Thatte; Piero L Olliaro; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2013-10-25

5.  Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.

Authors:  Chanaki Amaratunga; Sokunthea Sreng; Seila Suon; Erika S Phelps; Kasia Stepniewska; Pharath Lim; Chongjun Zhou; Sivanna Mao; Jennifer M Anderson; Niklas Lindegardh; Hongying Jiang; Jianping Song; Xin-zhuan Su; Nicholas J White; Arjen M Dondorp; Tim J C Anderson; Michael P Fay; Jianbing Mu; Socheat Duong; Rick M Fairhurst
Journal:  Lancet Infect Dis       Date:  2012-08-30       Impact factor: 25.071

6.  Spread of artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Elizabeth A Ashley; Mehul Dhorda; Rick M Fairhurst; Chanaki Amaratunga; Parath Lim; Seila Suon; Sokunthea Sreng; Jennifer M Anderson; Sivanna Mao; Baramey Sam; Chantha Sopha; Char Meng Chuor; Chea Nguon; Siv Sovannaroth; Sasithon Pukrittayakamee; Podjanee Jittamala; Kesinee Chotivanich; Kitipumi Chutasmit; Chaiyaporn Suchatsoonthorn; Ratchadaporn Runcharoen; Tran Tinh Hien; Nguyen Thanh Thuy-Nhien; Ngo Viet Thanh; Nguyen Hoan Phu; Ye Htut; Kay-Thwe Han; Kyin Hla Aye; Olugbenga A Mokuolu; Rasaq R Olaosebikan; Olaleke O Folaranmi; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Paul N Newton; Marie A Onyamboko; Caterina I Fanello; Antoinette K Tshefu; Neelima Mishra; Neena Valecha; Aung Pyae Phyo; Francois Nosten; Poravuth Yi; Rupam Tripura; Steffen Borrmann; Mahfudh Bashraheil; Judy Peshu; M Abul Faiz; Aniruddha Ghose; M Amir Hossain; Rasheda Samad; M Ridwanur Rahman; M Mahtabuddin Hasan; Akhterul Islam; Olivo Miotto; Roberto Amato; Bronwyn MacInnis; Jim Stalker; Dominic P Kwiatkowski; Zbynek Bozdech; Atthanee Jeeyapant; Phaik Yeong Cheah; Tharisara Sakulthaew; Jeremy Chalk; Benjamas Intharabut; Kamolrat Silamut; Sue J Lee; Benchawan Vihokhern; Chanon Kunasol; Mallika Imwong; Joel Tarning; Walter J Taylor; Shunmay Yeung; Charles J Woodrow; Jennifer A Flegg; Debashish Das; Jeffery Smith; Meera Venkatesan; Christopher V Plowe; Kasia Stepniewska; Philippe J Guerin; Arjen M Dondorp; Nicholas P Day; Nicholas J White
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

7.  Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.

Authors:  Yi Poravuth; Duong Socheat; Ronnatrai Rueangweerayut; Chirapong Uthaisin; Aung Pyae Phyo; Neena Valecha; B H Krishnamoorthy Rao; Emiliana Tjitra; Asep Purnama; Isabelle Borghini-Fuhrer; Stephan Duparc; Chang-Sik Shin; Lawrence Fleckenstein
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

8.  Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.

Authors:  Aung Pyae Phyo; Khin Maung Lwin; Ric N Price; Elizabeth A Ashley; Bruce Russell; Kanlaya Sriprawat; Niklas Lindegardh; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

9.  Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.

Authors:  Franklin Simoes de Santana Filho; Ana Ruth de Lima Arcanjo; Yonne Melo Chehuan; Monica Regina Costa; Flor Ernestina Martinez-Espinosa; Jose Luis Vieira; Maria das Graças Vale Barbosa; Wilson Duarte Alecrim; Maria das Graças Costa Alecrim
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

10.  G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.

Authors:  Nimol Khim; Christophe Benedet; Saorin Kim; Sim Kheng; Sovannaroth Siv; Rithea Leang; Soley Lek; Sinuon Muth; Nguon Chea; Char Meng Chuor; Socheat Duong; Alexandra Kerleguer; Pety Tor; Pheaktra Chim; Lydie Canier; Benoit Witkowski; Walter R J Taylor; Didier Ménard
Journal:  Malar J       Date:  2013-05-28       Impact factor: 2.979
View more
  10 in total

Review 1.  Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.

Authors:  Benjamin J Visser; Rosanne W Wieten; Daniëlle Kroon; Ingeborg M Nagel; Sabine Bélard; Michèle van Vugt; Martin P Grobusch
Journal:  Malar J       Date:  2014-11-26       Impact factor: 2.979

2.  Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.

Authors:  Stanislaw J Gabryszewski; Charin Modchang; Lise Musset; Thanat Chookajorn; David A Fidock
Journal:  Mol Biol Evol       Date:  2016-02-22       Impact factor: 16.240

3.  Independent Origin and Global Distribution of Distinct Plasmodium vivax Duffy Binding Protein Gene Duplications.

Authors:  Jessica B Hostetler; Eugenia Lo; Usheer Kanjee; Chanaki Amaratunga; Seila Suon; Sokunthea Sreng; Sivanna Mao; Delenasaw Yewhalaw; Anjali Mascarenhas; Dominic P Kwiatkowski; Marcelo U Ferreira; Pradipsinh K Rathod; Guiyun Yan; Rick M Fairhurst; Manoj T Duraisingh; Julian C Rayner
Journal:  PLoS Negl Trop Dis       Date:  2016-10-31

Review 4.  Management of relapsing Plasmodium vivax malaria.

Authors:  Cindy S Chu; Nicholas J White
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-31       Impact factor: 5.091

5.  Plasmodium vivax Malaria in Cambodia.

Authors:  Sovannaroth Siv; Arantxa Roca-Feltrer; Seshu Babu Vinjamuri; Denis Mey Bouth; Dysoley Lek; Mohammad Abdur Rashid; Ngau Peng By; Jean Popovici; Rekol Huy; Didier Menard
Journal:  Am J Trop Med Hyg       Date:  2016-10-05       Impact factor: 2.345

6.  Molecular Surveillance and Ex Vivo Drug Susceptibilities of Plasmodium vivax Isolates From the China-Myanmar Border.

Authors:  Weilin Zeng; Hui Zhao; Wei Zhao; Qi Yang; Xinxin Li; Xiaosong Li; Mengxi Duan; Xun Wang; Cuiying Li; Zheng Xiang; Xi Chen; Liwang Cui; Zhaoqing Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-01       Impact factor: 5.293

7.  Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.

Authors:  Suwanna Chaorattanakawee; Chanthap Lon; Soklyda Chann; Kheang Heng Thay; Nareth Kong; Yom You; Siratchana Sundrakes; Chatchadaporn Thamnurak; Sorayut Chattrakarn; Chantida Praditpol; Kritsanai Yingyuen; Mariusz Wojnarski; Rekol Huy; Michele D Spring; Douglas S Walsh; Jaymin C Patel; Jessica Lin; Jonathan J Juliano; Charlotte A Lanteri; David L Saunders
Journal:  Malar J       Date:  2017-09-30       Impact factor: 2.979

8.  Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.

Authors:  Jiangyan Li; Jie Zhang; Qian Li; Yue Hu; Yonghua Ruan; Zhiyong Tao; Hui Xia; Jichen Qiao; Lingwen Meng; Weilin Zeng; Cuiying Li; Xi He; Luyi Zhao; Faiza A Siddiqui; Jun Miao; Zhaoqing Yang; Qiang Fang; Liwang Cui
Journal:  PLoS Negl Trop Dis       Date:  2020-06-12

Review 9.  The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health.

Authors:  Lemu Golassa; Lucas Amenga-Etego; Eugenia Lo; Alfred Amambua-Ngwa
Journal:  Malar J       Date:  2020-08-24       Impact factor: 2.979

Review 10.  Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.

Authors:  Zi-Ning Lei; Zhuo-Xun Wu; Shaowei Dong; Dong-Hua Yang; Litu Zhang; Zunfu Ke; Chang Zou; Zhe-Sheng Chen
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.